Cybin to participate in the canaccord genuity 43rd annual growth conference

Toronto--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a fireside chat at the canaccord genuity 43rd annual growth conference, taking place august 7-10, 2023 in boston, ma. mr. drysdale's fireside chat.
CYBN Ratings Summary
CYBN Quant Ranking